N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2 Puritas ≥99.0% Argatroban Intermediate

Description:

Nomen: N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester

Synonyma: Argatroban medium-5

CAS: 74874-09-2

Aspectus: Alba vel Off-White Crystalline pulveris

Puritas: ≥99.0%

Medium Argatroban, Syntheticum Antithromboticum Agent

E-mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester
Synonyma Argatroban medium-5
CAS Number 74874-09-2
CATTUS Number RF-PI268
Stock Status In Stock, Productio Ascendite usque ad Centum chiliogrammata
Formulae hypotheticae C25H35N7O7S
M. Pondus 577.65
Shipping Condition Uit sub Ambient Temperature
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White Crystalline pulveris
Puritas ≥99.0%
Substantia cognata ≤2.0%
Enantiomorph ≤0.30%
RELICTUM Solvents
Methanol ≤0.30%
Ethanol ≤0.50%
Dichloromethane ≤0.03%
Ether acetic ≤0.50%
Triethylamine ≤0.03%
Toluene ≤0.10%
Metalla gravis ≤20ppm
Damnum in Siccatio ≤0.50%
Residere in Ignition ≤0.20%
Test Standard Enterprise Standard
Consuetudinem Argatroban medium-5

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, umore et peste infestatione.

commoda:

1

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarius fabrica et supplementum Argatrobanum intermedium-5, N-Nitro-I,2,3,4-tetradehydro Argatroban Ethyl Ester (CAS: 74874-09-2) cum qualitate alta;est medium Argatroban Monohydratum (CAS 141396-28-3) vel Argatroban Anhydrous (CAS 74863-84-6).

Argatroban est novum agens syntheticum antithromboticum ad conservationem anticoagulationis earum ictu ischemico utilem et coagulationem intravascularium disseminatam.Argatroban est anticoagulans, qui potentem, seletivum, univalentem directum thrombin inhibitorem agit.Argatroban anno 2000 probatum est pro prophylaxi vel thrombosis in aegris cum thrombocytopenia heparin inducto (HIT).

Epistulam tuam hic scribe et mitte nobis